Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sujal Shah currently holds 12,845 shares of CymaBay Therapeutics, Inc. (CBAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sujal Shah has been a net seller of CBAY stock. They have purchased $630.1K and sold $3.2M worth of shares.
Sujal Shah's most recent insider trade was on Mar 22, 2024, when they sold 88,351 shares at $0.00 per share.
Sujal Shah serves as Executive at CymaBay Therapeutics, Inc. (CBAY). They have executed 62 insider transactions totaling $3.9M over their tenure at the company.
Sujal Shah holds the position of Executive at CymaBay Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Sujal Shah has shown a selling trading pattern, with $630.1K in total purchases and $3.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sujal Shah was on Dec 11, 2023, when they sold $1.3M worth of CBAY shares. This transaction involved 63,975 shares at $19.99 per share.
Sujal Shah currently owns 12,845 shares of CymaBay Therapeutics, Inc. (CBAY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sujal Shah's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sujal Shah has 62 Form 4 filings on record as an insider at CymaBay Therapeutics, Inc..
Set alerts for Sujal Shah and 40,000+ other insiders.